Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2003
08/07/2003US20030149239 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030149238 Novel compounds
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030148990 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs
08/07/2003US20030148985 Methods and reagents for the inhibition of hepatitis B virus replication
08/07/2003US20030148982 Bi-spcific chimeric T cells
08/07/2003US20030148976 For therapy of cancer, infectious disease, and allergic disorders
08/07/2003US20030148970 Contacting the cell with an antisense oligonucleotide complementary to a region of RNA that encodes a portion of HDAC-4 (histone deacetylase) 4, whereby HDAC-4 activity is inhibited
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148934 Human growth factor modulators (GFMO) polynucleotides which identify and encode GFMO; amino acid sequences, expression vectors, host cells, antibodies, agonists, and antagonists; anticarcinogenic agents; fibrotic disorders
08/07/2003US20030148920 For inhibiting tumor-induced angiogenesis; antiischemic agents
08/07/2003US20030148522 Equine infectious anemia viral plasmid for transfection of heterologous genes into mammalian cells
08/07/2003US20030148518 Preparing and propagating tissue of himalayan medicinal plant for extraction of anticarcinogenic/antitumor agents
08/07/2003US20030148517 Preparation and compositions for antrodia camphorata mycelium biologically active material
08/07/2003US20030148516 Medium containing flt3 ligand for culturing hematophoietic cells
08/07/2003US20030148515 Generating blood producing tissues from central nervous system pluripotent cells for repair, regeneration or augmentation of mammalian hematopoietic system; gene therapy; tissue engineering; blood disorders; anticarcinogenic agents
08/07/2003US20030148514 Human embryonic germ cell line and methods of use
08/07/2003US20030148513 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
08/07/2003US20030148512 Preparing culture of vascular system progenitor cells for tissue engineering and treatment of vascular disorders
08/07/2003US20030148511 Induction of immunity using inhibitors of granzymes
08/07/2003US20030148510 Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells
08/07/2003US20030148508 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
08/07/2003US20030148507 RNA interference mediated inhibition of prostaglandin D2 receptor (PTGDR) and prostaglandin D2 synthetase (PTGDS) gene expression using short interfering RNA
08/07/2003US20030148499 Media and methods for cultivation of microorganisms
08/07/2003US20030148496 Cell-free system for translation and formation of HTLV lymphadenopathy associated viral coat proteins; viricides; drug screening
08/07/2003US20030148493 Sialidase and recombinant cell lines
08/07/2003US20030148491 Comprises receptor-like protein tyrosine phosphatase polypeptides (DEP-1) for use as antiinflammatory/anticarcinogenic agents
08/07/2003US20030148458 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/07/2003US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor
08/07/2003US20030148446 Acute neuronal induced calcium binding protein type 1 ligand
08/07/2003US20030148444 Sodium-independent small neutral amino acid transporters transporting L- and D-amino acids and genes thereof
08/07/2003US20030148443 Epoxide hydrolases, nucleic acids encoding them and methods of making and using them
08/07/2003US20030148442 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148438 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148436 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148434 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148433 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148432 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148430 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148426 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148425 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148423 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148420 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003US20030148419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148416 Isoprenoid production
08/07/2003US20030148409 Genetically engineered monoclonal di/tri/tetra antibodies preferential tumor associated antigens for use in diagnosis and treatment of tumors
08/07/2003US20030148390 Dose response-based methods for identifying receptors having alterations in signaling
08/07/2003US20030148389 Schizophrenia related gene and protein
08/07/2003US20030148388 Patched genes and uses related thereto
08/07/2003US20030148382 PanCAM nucleic acids and polypeptides
08/07/2003US20030148378 Phosphodiesterase 10
08/07/2003US20030148376 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148373 Comprises nucleotide sequences coding membrane protein/pro-polypeptide; antitumor agents; drug screening
08/07/2003US20030148371 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148370 Comprises nucleotide sequences coding membrane protein/pro-polypeptide; antitumor agents; drug screening
08/07/2003US20030148356 Amyloid precursor protein (APP); secretases
08/07/2003US20030148348 Self-replicating RNA molecule from hepatitis C virus
08/07/2003US20030148333 HCV anti-core monoclonal antibodies
08/07/2003US20030148329 Variants of alpha-fetoprotein coding and expression sequences
08/07/2003US20030148316 Methods and compositions relating to plasmacytoid dendritic cells
08/07/2003US20030148306 Aggrecanase molecules
08/07/2003US20030148295 Endothelial cells; nucleotide sequences; microarrays; algorithms
08/07/2003US20030148294 DNA encoding novel chemokine receptors
08/07/2003US20030148274 Identification of neural defects associated with the nucleosomal assembly protein 112 gene
08/07/2003US20030148264 PDZ (PSD-95/Discs large/ZO-I) domains, (PSD-95 = post-synaptic density protein-95); PDZ proteins involved in assembling ion channels and other transmembrane receptors, at specialized subcellular sites such as tight junctions
08/07/2003US20030148262 Chimeric alphavirus replicon particles
08/07/2003US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof
08/07/2003US20030147919 Producing empty, and thus non-infectious, parvovirus capsids, and to diagnostic assays and vaccines utilizing same; packaging and transferring nucleic acids
08/07/2003US20030147909 Protein naturally obtained through the activation of the immune system of fish inoculated with the pathogen; for aquaculture
08/07/2003US20030147907 Retroviral vectors
08/07/2003US20030147905 Administering an oligopeptide for immunotherapy
08/07/2003US20030147903 ABC transport polynucleotides, polypeptides and antibodies
08/07/2003US20030147902 Method of stimulating and immune response by administration of host organisms that express intimin alone of as a fusion protein with one of more other antigens
08/07/2003US20030147894 Useful in the field of remedies for myelocytic leukemia; binds to the myeloid cells
08/07/2003US20030147893 Novel human transmembrane 4 superfamily protein
08/07/2003US20030147887 B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies
08/07/2003US20030147886 Novel antibody compositions for preparing enriched dendritic cell preparations
08/07/2003US20030147883 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
08/07/2003US20030147880 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy
08/07/2003US20030147873 Cell culture prodcut for treating a behavioral or psychological disorders and brian disorders, brain transplant; stem cells
08/07/2003US20030147869 Cell proliferation for use in immunotherapeutic treatment for cancer and infectious diseases, CD32 antigen
08/07/2003US20030147868 A gene therapy, transfecting cells with exogenous genetic DNA for coding a desired therapeutic proteins, culturing the cells, for large-scale protein production
08/07/2003US20030147867 Gene therapy for antagonizing a transforming growth factors-beta; anticarcinogenic agents
08/07/2003US20030147866 Novel BGP compounds for therapy and diagnosis and methods for using same
08/07/2003US20030147863 Antisense modulation of TFAP2C expression
08/07/2003US20030147861 Compounds and methods for the modulation of immune responses
08/07/2003US20030147859 Administering to the recipient a dose of cultured cells from the donor, before the transplant surgery; administering antigenic determinant for treating autoimmune disease
08/07/2003US20030147854 Adenovirus vectors for gene therapy
08/07/2003US20030147847 Isolated nucleic acid encoding a protein comprising a glycosylphosphatidyl inositol-1 polypeptide can enhance the cytolytic activity of peripheral blood mononuclear cells
08/07/2003US20030147846 Methods of using macrophage inflammatory protein-4 (MIP-4) and myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides
08/07/2003US20030147831 Hair follicle growth
1 ... 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 ... 1827